Insider trades

Greg Keenan, Chief Officer of Aurinia Pharmaceuticals AUPH, has filed 0 purchases and 3 sales on the open market. The latest trade was on 03/06.

Greg Keenan

SVP, Chief Medical Officer
First filing
25/03/07
Trades
9 trades
Buys / sales
0 / 3
12-month net buying
No record
Last trade
03/06

Trading activity

Transactions

Trade type
Open-market sale25/08/0125/08/0520,000 sh$10.50$210,000−13.0%
Open-market sale25/03/0725/03/078,305 sh$8.23$68,350.15−5.1%
Open-market sale25/03/0325/03/0412,239 sh$8.00$97,912−7.0%